Tolvaptan 70748-0238-06
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 12, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA216063
Need to source Tolvaptan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tolvaptan | 15 mg/1 |
Drug Class
Vasopressin V2 Receptor Antagonist [EPC]Vasopressin V2 Receptor Antagonist [EPC]Vasopressin V2 Receptor Antagonists [MoA]
Selected Package
70748-0238-06Selected30 TABLET in 1 BOTTLE (70748-238-06)